Nature Nanotechnology, Published online: 15 June 2026; doi:10.1038/s41565-026-02196-z A polymer-based nanoplatform that selectively degrades CD147 in liver cancer cells while sparing healthy tissues reprograms lactate metabolism, enhancing antitumor immunity and improving multiple liver cancer therapies.